期刊文献+

杭州地区老年汉族人群CYP2C19基因多态性分析 被引量:3

Analysis of CYP2C19 genetic polymorphisms in elderly Han population from Hangzhou region
下载PDF
导出
摘要 目的探讨杭州地区老年汉族人群CYP2C19基因多态性分布,从而为临床制定个体化用药方案提供参考。方法选取杭州地区老年汉族人群764名,采用基因芯片技术检测CYP2C19基因。结果共检测到6个基因型,CYP2C19*1/*1、*1/*2、*1/*3、*2/*2、*2/*3、*3/*3,基因频数分别为45.03%、33.51%、8.11%、8.77%、4.32%、0.26%。快代谢型(CYP2C19*1*1)占45.03%,中间代谢型(CYP2C19*1*2、*1*3)占41.62%,慢代谢型(CYP2C19*2*2、*2*3、*3*3)占13.35%。该结果与国内其他地区汉族人群差异无统计学意义(P>0.05),且不同性别的各代谢型基因型频率差异无统计学意义(P>0.05)。结论杭州地区老年汉族人群CYP2C19基因分布与国内其他地区汉族人群类似,性别与CYP2C19基因遗传多态性无相关性。 Objective To investigate the CYP2 C19 polymorphisms in elderly Han population from Hangzhou region. Methods The CYP2 C19 genotypes were detected by using gene chip in 764 elderly Han people from Hangzhou region. Results The frequencies of CYP2 C19*1/*1, *1/*2, *1/*3, *2/*2, *2/*3 and *3/*3 were 45.03%, 33.51%, 8.11%, 8.77%, 4.32% and 0.26%, respectively. According to the metabolic phenotype, the frequencies of extensive metabolizer genotype(CYP2 C19 *1*1), intermediate metabolizer genotype(CYP2 C19 *1*2 and *1*3) and poor metabolizer genotype(CYP2 C19 *2*2, *2*3 and *3*3) were 45.03%, 41.62% and 13.35%, respectively. The distribution of metabolic genotypes in Han Chinese revealed in this study were similar to those in other regions in China(P 0.05). There was no significant difference in CYP2 C19 gene polymorphisms between males and females(P 0.05). Conclusion There was no significant difference in CYP2 C19 genetic polymorphisms between Han Chinese population in Hangzhou and other regions, and also no difference between different genders.
出处 《浙江医学》 CAS 2017年第22期1969-1971,共3页 Zhejiang Medical Journal
基金 浙江省医药卫生科技项目(2012KYB002)
关键词 CYP2C19 基因多态性 老年人 CYP2C19 Genetic polymorphism Aged
  • 相关文献

参考文献8

二级参考文献44

  • 1胡祥鹏,许建明,胡咏梅,梅俏,徐新华,徐叔云.CYP2C19基因多态性对奥美拉唑在中国人体内的药物动力学和药效学的影响[J].中国药理学通报,2005,21(10):1210-1213. 被引量:28
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 3Wroblewski B,Glenn MB.The cytochrome P450 drug metabolizing enzyme system:an overview of potential clinicially important drug interactions[J].J Head Trauma Rebabil,2002;17:571-574.
  • 4Wedlund PJ,Aslanian WS,McAllister CB,et al.Mephenytoin hydroxylation deficiency in Caucasians:frequency of a new oxidative drug metabolism polymorphism[J].Clin Pharmacol Ther,1984;36:773-780.
  • 5Wrighton SA,Stevens JC,Becker GW,et al.Isolation and characterization of human liver cytochrome P450 2C19:correlation between 2C19 and S-mephenytoin 4'-hydroxylation[J].Arch Biochem Biophys,1993;306:240-245.
  • 6He N,Yan FX,Huang SL,et al.CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population[J].Eur J Clin Pharmacol,2002;58:15-18.
  • 7Kimura M,Ieiri I,Mamiya K,et al.Genetic Polymorphism of Cytochrome P450s,CYP2C19,and CYP2C9 in a Japanese Population[J].Ther Drug Monit,1998;20:243-247.
  • 8Roh HK,Dahl ML,Tybring G,et al.CYP2C19 genotype and phenotype determined by omeprazole in a Korean population[J].Pharmacogenetics,1996;6:547-551.
  • 9Chang M,Dahl ML,Tybring G,et al.Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians:Comparision with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype[J].Pharmacogenetics,1996;5:358-363.
  • 10Persson I,Aklillu E,Rodrigues F,et al.S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians[J].Pharmacogenetics,1996;6:521-526.

共引文献200

同被引文献36

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部